Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2021
ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “P28”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced a range of...